Summary
Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.
According to APO Research, The global Antacid market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Antacid is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Antacid is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Antacid is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Antacid is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Antacid include AstraZeneca, Takeda Pharmaceutical, Pfizer, Reckitt Benckiser, Bayer, Procter&Gamble, GlaxoSmithKline, Johnson&Johnson and CONBA, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Antacid, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Antacid, also provides the sales of main regions and countries. Of the upcoming market potential for Antacid, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antacid sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Antacid market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Antacid sales, projected growth trends, production technology, application and end-user industry.
Antacid Segment by Company
AstraZeneca
Takeda Pharmaceutical
Pfizer
Reckitt Benckiser
Bayer
Procter&Gamble
GlaxoSmithKline
Johnson&Johnson
CONBA
Xiuzheng Pharma
Sanofi
Bausch Health
CR SANJIU
Reddy's Laboratories
Antacid Segment by Type
Proton Pump Inhibitor
H2 Antagonist
Acid Neutralizers
Antacid Segment by Application
OTC Drug
Rx Drug
Antacid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antacid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antacid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antacid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Antacid in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Antacid manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antacid sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
- Market Overview
- Product Definition
- Antacid Market by Type
- Global Antacid Market Size by Type, 2020 VS 2024 VS 2031
- Proton Pump Inhibitor
- H2 Antagonist
- Acid Neutralizers
- Antacid Market by Application
- Global Antacid Market Size by Application, 2020 VS 2024 VS 2031
- OTC Drug
- Rx Drug
- Assumptions and Limitations
- Study Goals and Objectives
- Antacid Market Dynamics
- Antacid Industry Trends
- Antacid Industry Drivers
- Antacid Industry Opportunities and Challenges
- Antacid Industry Restraints
- Global Market Growth Prospects
- Global Antacid Revenue Estimates and Forecasts (2020-2031)
- Global Antacid Revenue by Region
- Global Antacid Revenue by Region: 2020 VS 2024 VS 2031
- Global Antacid Revenue by Region (2020-2025)
- Global Antacid Revenue by Region (2026-2031)
- Global Antacid Revenue Market Share by Region (2020-2031)
- Global Antacid Sales Estimates and Forecasts 2020-2031
- Global Antacid Sales by Region
- Global Antacid Sales by Region: 2020 VS 2024 VS 2031
- Global Antacid Sales by Region (2020-2025)
- Global Antacid Sales by Region (2026-2031)
- Global Antacid Sales Market Share by Region (2020-2031)
- US & Canada & Mexico
- Europe
- China
- Asia (Excluding China)
- South America, Middle East and Africa
- Market Competitive Landscape by Manufacturers
- Global Antacid Revenue by Manufacturers
- Global Antacid Revenue by Manufacturers (2020-2025)
- Global Antacid Revenue Market Share by Manufacturers (2020-2025)
- Global Antacid Manufacturers Revenue Share Top 10 and Top 5 in 2024
- Global Antacid Sales by Manufacturers
- Global Antacid Sales by Manufacturers (2020-2025)
- Global Antacid Sales Market Share by Manufacturers (2020-2025)
- Global Antacid Manufacturers Sales Share Top 10 and Top 5 in 2024
- Global Antacid Sales Price by Manufacturers (2020-2025)
- Global Antacid Key Manufacturers Ranking, 2023 VS 2024 VS 2025
- Global Antacid Key Manufacturers Manufacturing Sites & Headquarters
- Global Antacid Manufacturers, Product Type & Application
- Global Antacid Manufacturers' Establishment Date
- Market Competitive Analysis
- Global Antacid Market CR5 and HHI
- 2024 Antacid Tier 1, Tier 2, and Tier 3
- Global Antacid Revenue by Manufacturers
- Antacid Market by Type
- Global Antacid Revenue by Type
- Global Antacid Revenue by Type (2020 VS 2024 VS 2031)
- Global Antacid Revenue by Type (2020-2031) & (US$ Million)
- Global Antacid Revenue Market Share by Type (2020-2031)
- Global Antacid Sales by Type
- Global Antacid Sales by Type (2020 VS 2024 VS 2031)
- Global Antacid Sales by Type (2020-2031) & (M Units)
- Global Antacid Sales Market Share by Type (2020-2031)
- Global Antacid Price by Type
- Global Antacid Revenue by Type
- Antacid Market by Application
- Global Antacid Revenue by Application
- Global Antacid Revenue by Application (2020 VS 2024 VS 2031)
- Global Antacid Revenue by Application (2020-2031) & (US$ Million)
- Global Antacid Revenue Market Share by Application (2020-2031)
- Global Antacid Sales by Application
- Global Antacid Sales by Application (2020 VS 2024 VS 2031)
- Global Antacid Sales by Application (2020-2031) & (M Units)
- Global Antacid Sales Market Share by Application (2020-2031)
- Global Antacid Price by Application
- Global Antacid Revenue by Application
- Company Profiles
- AstraZeneca
- AstraZeneca Comapny Information
- AstraZeneca Business Overview
- AstraZeneca Antacid Sales, Revenue, Price and Gross Margin (2020-2025)
- AstraZeneca Antacid Product Portfolio
- AstraZeneca Recent Developments
- Takeda Pharmaceutical
- Takeda Pharmaceutical Comapny Information
- Takeda Pharmaceutical Business Overview
- Takeda Pharmaceutical Antacid Sales, Revenue, Price and Gross Margin (2020-2025)
- Takeda Pharmaceutical Antacid Product Portfolio
- Takeda Pharmaceutical Recent Developments
- Pfizer
- Pfizer Comapny Information
- Pfizer Business Overview
- Pfizer Antacid Sales, Revenue, Price and Gross Margin (2020-2025)
- Pfizer Antacid Product Portfolio
- Pfizer Recent Developments
- Reckitt Benckiser
- Reckitt Benckiser Comapny Information
- Reckitt Benckiser Business Overview
- Reckitt Benckiser Antacid Sales, Revenue, Price and Gross Margin (2020-2025)
- Reckitt Benckiser Antacid Product Portfolio
- Reckitt Benckiser Recent Developments
- Bayer
- Bayer Comapny Information
- Bayer Business Overview
- Bayer Antacid Sales, Revenue, Price and Gross Margin (2020-2025)
- Bayer Antacid Product Portfolio
- Bayer Recent Developments
- Procter&Gamble
- Procter&Gamble Comapny Information
- Procter&Gamble Business Overview
- Procter&Gamble Antacid Sales, Revenue, Price and Gross Margin (2020-2025)
- Procter&Gamble Antacid Product Portfolio
- Procter&Gamble Recent Developments
- GlaxoSmithKline
- GlaxoSmithKline Comapny Information
- GlaxoSmithKline Business Overview
- GlaxoSmithKline Antacid Sales, Revenue, Price and Gross Margin (2020-2025)
- GlaxoSmithKline Antacid Product Portfolio
- GlaxoSmithKline Recent Developments
- Johnson&Johnson
- Johnson&Johnson Comapny Information
- Johnson&Johnson Business Overview
- Johnson&Johnson Antacid Sales, Revenue, Price and Gross Margin (2020-2025)
- Johnson&Johnson Antacid Product Portfolio
- Johnson&Johnson Recent Developments
- CONBA
- CONBA Comapny Information
- CONBA Business Overview
- CONBA Antacid Sales, Revenue, Price and Gross Margin (2020-2025)
- CONBA Antacid Product Portfolio
- CONBA Recent Developments
- Xiuzheng Pharma
- Xiuzheng Pharma Comapny Information
- Xiuzheng Pharma Business Overview
- Xiuzheng Pharma Antacid Sales, Revenue, Price and Gross Margin (2020-2025)
- Xiuzheng Pharma Antacid Product Portfolio
- Xiuzheng Pharma Recent Developments
- Sanofi
- Sanofi Comapny Information
- Sanofi Business Overview
- Sanofi Antacid Sales, Revenue, Price and Gross Margin (2020-2025)
- Sanofi Antacid Product Portfolio
- Sanofi Recent Developments
- Bausch Health
- Bausch Health Comapny Information
- Bausch Health Business Overview
- Bausch Health Antacid Sales, Revenue, Price and Gross Margin (2020-2025)
- Bausch Health Antacid Product Portfolio
- Bausch Health Recent Developments
- CR SANJIU
- CR SANJIU Comapny Information
- CR SANJIU Business Overview
- CR SANJIU Antacid Sales, Revenue, Price and Gross Margin (2020-2025)
- CR SANJIU Antacid Product Portfolio
- CR SANJIU Recent Developments
- Reddy's Laboratories
- Reddy's Laboratories Comapny Information
- Reddy's Laboratories Business Overview
- Reddy's Laboratories Antacid Sales, Revenue, Price and Gross Margin (2020-2025)
- Reddy's Laboratories Antacid Product Portfolio
- Reddy's Laboratories Recent Developments
- AstraZeneca
- North America
- North America Antacid Market Size by Type
- North America Antacid Revenue by Type (2020-2031)
- North America Antacid Sales by Type (2020-2031)
- North America Antacid Price by Type (2020-2031)
- North America Antacid Market Size by Application
- North America Antacid Revenue by Application (2020-2031)
- North America Antacid Sales by Application (2020-2031)
- North America Antacid Price by Application (2020-2031)
- North America Antacid Market Size by Country
- North America Antacid Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- North America Antacid Sales by Country (2020 VS 2024 VS 2031)
- North America Antacid Price by Country (2020-2031)
- United States
- Canada
- Mexico
- North America Antacid Market Size by Type
- Europe
- Europe Antacid Market Size by Type
- Europe Antacid Revenue by Type (2020-2031)
- Europe Antacid Sales by Type (2020-2031)
- Europe Antacid Price by Type (2020-2031)
- Europe Antacid Market Size by Application
- Europe Antacid Revenue by Application (2020-2031)
- Europe Antacid Sales by Application (2020-2031)
- Europe Antacid Price by Application (2020-2031)
- Europe Antacid Market Size by Country
- Europe Antacid Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- Europe Antacid Sales by Country (2020 VS 2024 VS 2031)
- Europe Antacid Price by Country (2020-2031)
- Germany
- France
- U.K.
- Italy
- Russia
- Spain
- Netherlands
- Europe Antacid Market Size by Type
- China
- China Antacid Market Size by Type
- China Antacid Revenue by Type (2020-2031)
- China Antacid Sales by Type (2020-2031)
- China Antacid Price by Type (2020-2031)
- China Antacid Market Size by Application
- China Antacid Revenue by Application (2020-2031)
- China Antacid Sales by Application (2020-2031)
- China Antacid Price by Application (2020-2031)
- China Antacid Market Size by Type
- Asia (Excluding China)
- Asia Antacid Market Size by Type
- Asia Antacid Revenue by Type (2020-2031)
- Asia Antacid Sales by Type (2020-2031)
- Asia Antacid Price by Type (2020-2031)
- Asia Antacid Market Size by Application
- Asia Antacid Revenue by Application (2020-2031)
- Asia Antacid Sales by Application (2020-2031)
- Asia Antacid Price by Application (2020-2031)
- Asia Antacid Market Size by Country
- Asia Antacid Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- Asia Antacid Sales by Country (2020 VS 2024 VS 2031)
- Asia Antacid Price by Country (2020-2031)
- Japan
- South Korea
- India
- Australia
- Taiwan
- Southeast Asia
- Asia Antacid Market Size by Type
- South America, Middle East and Africa
- SAMEA Antacid Market Size by Type
- SAMEA Antacid Revenue by Type (2020-2031)
- SAMEA Antacid Sales by Type (2020-2031)
- SAMEA Antacid Price by Type (2020-2031)
- SAMEA Antacid Market Size by Application
- SAMEA Antacid Revenue by Application (2020-2031)
- SAMEA Antacid Sales by Application (2020-2031)
- SAMEA Antacid Price by Application (2020-2031)
- SAMEA Antacid Market Size by Country
- SAMEA Antacid Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- SAMEA Antacid Sales by Country (2020 VS 2024 VS 2031)
- SAMEA Antacid Price by Country (2020-2031)
- Brazil
- Argentina
- Chile
- Colombia
- Peru
- Saudi Arabia
- Israel
- UAE
- Turkey
- Iran
- Egypt
- SAMEA Antacid Market Size by Type
- Value Chain and Sales Channels Analysis
- Antacid Value Chain Analysis
- Antacid Key Raw Materials
- Raw Materials Key Suppliers
- Manufacturing Cost Structure
- Antacid Production Mode & Process
- Antacid Sales Channels Analysis
- Direct Comparison with Distribution Share
- Antacid Distributors
- Antacid Customers
- Antacid Value Chain Analysis
- Concluding Insights
- Appendix
- Reasons for Doing This Study
- Research Methodology
- Research Process
- Authors List of This Report
- Data Source
- Secondary Sources
- Primary Sources
- Disclaimer
List of Tables
Table 1 | :Global Antacid Market Size Growth Rate by Type (US$ Million), 2020 VS 2024 VS 2031 |
Table 2 | :Proton Pump Inhibitor Major Manufacturers |
Table 3 | :H2 Antagonist Major Manufacturers |
Table 4 | :Acid Neutralizers Major Manufacturers |
Table 5 | :Global Antacid Market Size Growth Rate by Application (US$ Million), 2020 VS 2024 VS 2031 |
Table 6 | :OTC Drug Major Manufacturers |
Table 7 | :Rx Drug Major Manufacturers |
Table 8 | :Antacid Industry Trends |
Table 9 | :Antacid Industry Drivers |
Table 10 | :Antacid Industry Opportunities and Challenges |
Table 11 | :Antacid Industry Restraints |
Table 12 | :Global Antacid Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million) |
Table 13 | :Global Antacid Revenue by Region (2020-2025) & (US$ Million) |
Table 14 | :Global Antacid Revenue by Region (2026-2031) & (US$ Million) |
Table 15 | :Global Antacid Revenue Market Share by Region (2020-2025) |
Table 16 | :Global Antacid Revenue Market Share by Region (2026-2031) |
Table 17 | :Global Antacid Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (M Units) |
Table 18 | :Global Antacid Sales by Region (2020-2025) & (M Units) |
Table 19 | :Global Antacid Sales by Region (2026-2031) & (M Units) |
Table 20 | :Global Antacid Sales Market Share by Region (2020-2025) |
Table 21 | :Global Antacid Sales Market Share by Region (2026-2031) |
Table 22 | :Global Antacid Revenue by Manufacturers (US$ Million) & (2020-2025) |
Table 23 | :Global Antacid Revenue Market Share by Manufacturers (2020-2025) |
Table 24 | :Global Antacid Sales by Manufacturers (US$ Million) & (2020-2025) |
Table 25 | :Global Antacid Sales Market Share by Manufacturers (2020-2025) |
Table 26 | :Global Antacid Sales Price (USD/Unit) of Manufacturers (2020-2025) |
Table 27 | :Global Antacid Key Manufacturers Ranking, 2023 VS 2024 VS 2025 |
Table 28 | :Global Antacid Key Manufacturers Manufacturing Sites & Headquarters |
Table 29 | :Global Antacid Manufacturers, Product Type & Application |
Table 30 | :Global Antacid Manufacturers' Establishment Date |
Table 31 | :Global Manufacturers Market Concentration Ratio (CR5 and HHI) |
Table 32 | :Global Antacid by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024) |
Table 33 | :Global Antacid Revenue by Type 2020 VS 2024 VS 2031 (US$ Million) |
Table 34 | :Global Antacid Revenue by Type (2020-2025) & (US$ Million) |
Table 35 | :Global Antacid Revenue by Type (2026-2031) & (US$ Million) |
Table 36 | :Global Antacid Revenue Market Share by Type (2020-2025) |
Table 37 | :Global Antacid Revenue Market Share by Type (2026-2031) |
Table 38 | :Global Antacid Sales by Type 2020 VS 2024 VS 2031 (M Units) |
Table 39 | :Global Antacid Sales by Type (2020-2025) & (M Units) |
Table 40 | :Global Antacid Sales by Type (2026-2031) & (M Units) |
Table 41 | :Global Antacid Sales Market Share by Type (2020-2025) |
Table 42 | :Global Antacid Sales Market Share by Type (2026-2031) |
Table 43 | :Global Antacid Price by Type (2020-2025) & (USD/Unit) |
Table 44 | :Global Antacid Price by Type (2026-2031) & (USD/Unit) |
Table 45 | :Global Antacid Revenue by Application 2020 VS 2024 VS 2031 (US$ Million) |
Table 46 | :Global Antacid Revenue by Application (2020-2025) & (US$ Million) |
Table 47 | :Global Antacid Revenue by Application (2026-2031) & (US$ Million) |
Table 48 | :Global Antacid Revenue Market Share by Application (2020-2025) |
Table 49 | :Global Antacid Revenue Market Share by Application (2026-2031) |
Table 50 | :Global Antacid Sales by Application 2020 VS 2024 VS 2031 (M Units) |
Table 51 | :Global Antacid Sales by Application (2020-2025) & (M Units) |
Table 52 | :Global Antacid Sales by Application (2026-2031) & (M Units) |
Table 53 | :Global Antacid Sales Market Share by Application (2020-2025) |
Table 54 | :Global Antacid Sales Market Share by Application (2026-2031) |
Table 55 | :Global Antacid Price by Application (2020-2025) & (USD/Unit) |
Table 56 | :Global Antacid Price by Application (2026-2031) & (USD/Unit) |
Table 57 | :AstraZeneca Company Information |
Table 58 | :AstraZeneca Business Overview |
Table 59 | :AstraZeneca Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025) |
Table 60 | :AstraZeneca Antacid Product Portfolio |
Table 61 | :AstraZeneca Recent Development |
Table 62 | :Takeda Pharmaceutical Company Information |
Table 63 | :Takeda Pharmaceutical Business Overview |
Table 64 | :Takeda Pharmaceutical Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025) |
Table 65 | :Takeda Pharmaceutical Antacid Product Portfolio |
Table 66 | :Takeda Pharmaceutical Recent Development |
Table 67 | :Pfizer Company Information |
Table 68 | :Pfizer Business Overview |
Table 69 | :Pfizer Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025) |
Table 70 | :Pfizer Antacid Product Portfolio |
Table 71 | :Pfizer Recent Development |
Table 72 | :Reckitt Benckiser Company Information |
Table 73 | :Reckitt Benckiser Business Overview |
Table 74 | :Reckitt Benckiser Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025) |
Table 75 | :Reckitt Benckiser Antacid Product Portfolio |
Table 76 | :Reckitt Benckiser Recent Development |
Table 77 | :Bayer Company Information |
Table 78 | :Bayer Business Overview |
Table 79 | :Bayer Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025) |
Table 80 | :Bayer Antacid Product Portfolio |
Table 81 | :Bayer Recent Development |
Table 82 | :Procter&Gamble Company Information |
Table 83 | :Procter&Gamble Business Overview |
Table 84 | :Procter&Gamble Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025) |
Table 85 | :Procter&Gamble Antacid Product Portfolio |
Table 86 | :Procter&Gamble Recent Development |
Table 87 | :GlaxoSmithKline Company Information |
Table 88 | :GlaxoSmithKline Business Overview |
Table 89 | :GlaxoSmithKline Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025) |
Table 90 | :GlaxoSmithKline Antacid Product Portfolio |
Table 91 | :GlaxoSmithKline Recent Development |
Table 92 | :Johnson&Johnson Company Information |
Table 93 | :Johnson&Johnson Business Overview |
Table 94 | :Johnson&Johnson Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025) |
Table 95 | :Johnson&Johnson Antacid Product Portfolio |
Table 96 | :Johnson&Johnson Recent Development |
Table 97 | :CONBA Company Information |
Table 98 | :CONBA Business Overview |
Table 99 | :CONBA Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025) |
Table 100 | :CONBA Antacid Product Portfolio |
Table 101 | :CONBA Recent Development |
Table 102 | :Xiuzheng Pharma Company Information |
Table 103 | :Xiuzheng Pharma Business Overview |
Table 104 | :Xiuzheng Pharma Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025) |
Table 105 | :Xiuzheng Pharma Antacid Product Portfolio |
Table 106 | :Xiuzheng Pharma Recent Development |
Table 107 | :Sanofi Company Information |
Table 108 | :Sanofi Business Overview |
Table 109 | :Sanofi Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025) |
Table 110 | :Sanofi Antacid Product Portfolio |
Table 111 | :Sanofi Recent Development |
Table 112 | :Bausch Health Company Information |
Table 113 | :Bausch Health Business Overview |
Table 114 | :Bausch Health Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025) |
Table 115 | :Bausch Health Antacid Product Portfolio |
Table 116 | :Bausch Health Recent Development |
Table 117 | :CR SANJIU Company Information |
Table 118 | :CR SANJIU Business Overview |
Table 119 | :CR SANJIU Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025) |
Table 120 | :CR SANJIU Antacid Product Portfolio |
Table 121 | :CR SANJIU Recent Development |
Table 122 | :Reddy's Laboratories Company Information |
Table 123 | :Reddy's Laboratories Business Overview |
Table 124 | :Reddy's Laboratories Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025) |
Table 125 | :Reddy's Laboratories Antacid Product Portfolio |
Table 126 | :Reddy's Laboratories Recent Development |
Table 127 | :North America Antacid Revenue by Type (2020-2025) & (US$ Million) |
Table 128 | :North America Antacid Revenue by Type (2026-2031) & (US$ Million) |
Table 129 | :North America Antacid Sales by Type (2020-2025) & (M Units) |
Table 130 | :North America Antacid Sales by Type (2026-2031) & (M Units) |
Table 131 | :North America Antacid Sales Price by Type (2020-2025) & (USD/Unit) |
Table 132 | :North America Antacid Sales Price by Type (2026-2031) & (USD/Unit) |
Table 133 | :North America Antacid Revenue by Application (2020-2025) & (US$ Million) |
Table 134 | :North America Antacid Revenue by Application (2026-2031) & (US$ Million) |
Table 135 | :North America Antacid Sales by Application (2020-2025) & (M Units) |
Table 136 | :North America Antacid Sales by Application (2026-2031) & (M Units) |
Table 137 | :North America Antacid Sales Price by Application (2020-2025) & (USD/Unit) |
Table 138 | :North America Antacid Sales Price by Application (2026-2031) & (USD/Unit) |
Table 139 | :North America Antacid Revenue Grow Rate by Country (2020 VS 2024 VS 2031) & (US$ Million) |
Table 140 | :North America Antacid Revenue Grow Rate by Country (2020-2025) & (US$ Million) |
Table 141 | :North America Antacid Revenue Grow Rate by Country (2026-2031) & (US$ Million) |
Table 142 | :North America Antacid Sales by Country (2020 VS 2024 VS 2031) & (M Units) |
Table 143 | :North America Antacid Sales by Country (2020-2025) & (M Units) |
Table 144 | :North America Antacid Sales by Country (2026-2031) & (M Units) |
Table 145 | :North America Antacid Sales Price by Country (2020-2025) & (USD/Unit) |
Table 146 | :North America Antacid Sales Price by Country (2026-2031) & (USD/Unit) |
Table 147 | :United States Antacid Revenue (2020-2031) & (US$ Million) |
Table 148 | :Canada Antacid Revenue (2020-2031) & (US$ Million) |
Table 149 | :Mexico Antacid Revenue (2020-2031) & (US$ Million) |
Table 150 | :Europe Antacid Revenue by Type (2020-2025) & (US$ Million) |
Table 151 | :Europe Antacid Revenue by Type (2026-2031) & (US$ Million) |
Table 152 | :Europe Antacid Sales by Type (2020-2025) & (M Units) |
Table 153 | :Europe Antacid Sales by Type (2026-2031) & (M Units) |
Table 154 | :Europe Antacid Sales Price by Type (2020-2025) & (USD/Unit) |
Table 155 | :Europe Antacid Sales Price by Type (2026-2031) & (USD/Unit) |
Table 156 | :Europe Antacid Revenue by Application (2020-2025) & (US$ Million) |
Table 157 | :Europe Antacid Revenue by Application (2026-2031) & (US$ Million) |
Table 158 | :Europe Antacid Sales by Application (2020-2025) & (M Units) |
Table 159 | :Europe Antacid Sales by Application (2026-2031) & (M Units) |
Table 160 | :Europe Antacid Sales Price by Application (2020-2025) & (USD/Unit) |
Table 161 | :Europe Antacid Sales Price by Application (2026-2031) & (USD/Unit) |
Table 162 | :Europe Antacid Revenue Grow Rate by Country (2020 VS 2024 VS 2031) & (US$ Million) |
Table 163 | :Europe Antacid Revenue Grow Rate by Country (2020-2025) & (US$ Million) |
Table 164 | :Europe Antacid Revenue Grow Rate by Country (2026-2031) & (US$ Million) |
Table 165 | :Europe Antacid Sales by Country (2020 VS 2024 VS 2031) & (M Units) |
Table 166 | :Europe Antacid Sales by Country (2020-2025) & (M Units) |
Table 167 | :Europe Antacid Sales by Country (2026-2031) & (M Units) |
Table 168 | :Europe Antacid Sales Price by Country (2020-2025) & (USD/Unit) |
Table 169 | :Europe Antacid Sales Price by Country (2026-2031) & (USD/Unit) |
Table 170 | :Germany Antacid Revenue (2020-2031) & (US$ Million) |
Table 171 | :France Antacid Revenue (2020-2031) & (US$ Million) |
Table 172 | :U.K. Antacid Revenue (2020-2031) & (US$ Million) |
Table 173 | :Italy Antacid Revenue (2020-2031) & (US$ Million) |
Table 174 | :Russia Antacid Revenue (2020-2031) & (US$ Million) |
Table 175 | :Spain Antacid Revenue (2020-2031) & (US$ Million) |
Table 176 | :Netherlands Antacid Revenue (2020-2031) & (US$ Million) |
Table 177 | :Switzerland Antacid Revenue (2020-2031) & (US$ Million) |
Table 178 | :Sweden Antacid Revenue (2020-2031) & (US$ Million) |
Table 179 | :Poland Antacid Revenue (2020-2031) & (US$ Million) |
Table 180 | :China Antacid Revenue by Type (2020-2025) & (US$ Million) |
Table 181 | :China Antacid Revenue by Type (2026-2031) & (US$ Million) |
Table 182 | :China Antacid Sales by Type (2020-2025) & (M Units) |
Table 183 | :China Antacid Sales by Type (2026-2031) & (M Units) |
Table 184 | :China Antacid Sales Price by Type (2020-2025) & (USD/Unit) |
Table 185 | :China Antacid Sales Price by Type (2026-2031) & (USD/Unit) |
Table 186 | :China Antacid Revenue by Application (2020-2025) & (US$ Million) |
Table 187 | :China Antacid Revenue by Application (2026-2031) & (US$ Million) |
Table 188 | :China Antacid Sales by Application (2020-2025) & (M Units) |
Table 189 | :China Antacid Sales by Application (2026-2031) & (M Units) |
Table 190 | :China Antacid Sales Price by Application (2020-2025) & (USD/Unit) |
Table 191 | :China Antacid Sales Price by Application (2026-2031) & (USD/Unit) |
Table 192 | :Asia Antacid Revenue by Type (2020-2025) & (US$ Million) |
Table 193 | :Asia Antacid Revenue by Type (2026-2031) & (US$ Million) |
Table 194 | :Asia Antacid Sales by Type (2020-2025) & (M Units) |
Table 195 | :Asia Antacid Sales by Type (2026-2031) & (M Units) |
Table 196 | :Asia Antacid Sales Price by Type (2020-2025) & (USD/Unit) |
Table 197 | :Asia Antacid Sales Price by Type (2026-2031) & (USD/Unit) |
Table 198 | :Asia Antacid Revenue by Application (2020-2025) & (US$ Million) |
Table 199 | :Asia Antacid Revenue by Application (2026-2031) & (US$ Million) |
Table 200 | :Asia Antacid Sales by Application (2020-2025) & (M Units) |
Table 201 | :Asia Antacid Sales by Application (2026-2031) & (M Units) |
Table 202 | :Asia Antacid Sales Price by Application (2020-2025) & (USD/Unit) |
Table 203 | :Asia Antacid Sales Price by Application (2026-2031) & (USD/Unit) |
Table 204 | :Asia Antacid Revenue Grow Rate by Country (2020 VS 2024 VS 2031) & (US$ Million) |
Table 205 | :Asia Antacid Revenue Grow Rate by Country (2020-2025) & (US$ Million) |
Table 206 | :Asia Antacid Revenue Grow Rate by Country (2026-2031) & (US$ Million) |
Table 207 | :Asia Antacid Sales by Country (2020 VS 2024 VS 2031) & (M Units) |
Table 208 | :Asia Antacid Sales by Country (2020-2025) & (M Units) |
Table 209 | :Asia Antacid Sales by Country (2026-2031) & (M Units) |
Table 210 | :Asia Antacid Sales Price by Country (2020-2025) & (USD/Unit) |
Table 211 | :Asia Antacid Sales Price by Country (2026-2031) & (USD/Unit) |
Table 212 | :Japan Antacid Revenue (2020-2031) & (US$ Million) |
Table 213 | :South Korea Antacid Revenue (2020-2031) & (US$ Million) |
Table 214 | :India Antacid Revenue (2020-2031) & (US$ Million) |
Table 215 | :Australia Antacid Revenue (2020-2031) & (US$ Million) |
Table 216 | :Taiwan Antacid Revenue (2020-2031) & (US$ Million) |
Table 217 | :Southeast Asia Antacid Revenue (2020-2031) & (US$ Million) |
Table 218 | :SAMEA Antacid Revenue by Type (2020-2025) & (US$ Million) |
Table 219 | :SAMEA Antacid Revenue by Type (2026-2031) & (US$ Million) |
Table 220 | :SAMEA Antacid Sales by Type (2020-2025) & (M Units) |
Table 221 | :SAMEA Antacid Sales by Type (2026-2031) & (M Units) |
Table 222 | :SAMEA Antacid Sales Price by Type (2020-2025) & (USD/Unit) |
Table 223 | :SAMEA Antacid Sales Price by Type (2026-2031) & (USD/Unit) |
Table 224 | :SAMEA Antacid Revenue by Application (2020-2025) & (US$ Million) |
Table 225 | :SAMEA Antacid Revenue by Application (2026-2031) & (US$ Million) |
Table 226 | :SAMEA Antacid Sales by Application (2020-2025) & (M Units) |
Table 227 | :SAMEA Antacid Sales by Application (2026-2031) & (M Units) |
Table 228 | :SAMEA Antacid Sales Price by Application (2020-2025) & (USD/Unit) |
Table 229 | :SAMEA Antacid Sales Price by Application (2026-2031) & (USD/Unit) |
Table 230 | :SAMEA Antacid Revenue Grow Rate by Country (2020 VS 2024 VS 2031) & (US$ Million) |
Table 231 | :SAMEA Antacid Revenue Grow Rate by Country (2020-2025) & (US$ Million) |
Table 232 | :SAMEA Antacid Revenue Grow Rate by Country (2026-2031) & (US$ Million) |
Table 233 | :SAMEA Antacid Sales by Country (2020 VS 2024 VS 2031) & (M Units) |
Table 234 | :SAMEA Antacid Sales by Country (2020-2025) & (M Units) |
Table 235 | :SAMEA Antacid Sales by Country (2026-2031) & (M Units) |
Table 236 | :SAMEA Antacid Sales Price by Country (2020-2025) & (USD/Unit) |
Table 237 | :SAMEA Antacid Sales Price by Country (2026-2031) & (USD/Unit) |
Table 238 | :Brazil Antacid Revenue (2020-2031) & (US$ Million) |
Table 239 | :Argentina Antacid Revenue (2020-2031) & (US$ Million) |
Table 240 | :Chile Antacid Revenue (2020-2031) & (US$ Million) |
Table 241 | :Colombia Antacid Revenue (2020-2031) & (US$ Million) |
Table 242 | :Peru Antacid Revenue (2020-2031) & (US$ Million) |
Table 243 | :Saudi Arabia Antacid Revenue (2020-2031) & (US$ Million) |
Table 244 | :Israel Antacid Revenue (2020-2031) & (US$ Million) |
Table 245 | :UAE Antacid Revenue (2020-2031) & (US$ Million) |
Table 246 | :Turkey Antacid Revenue (2020-2031) & (US$ Million) |
Table 247 | :Iran Antacid Revenue (2020-2031) & (US$ Million) |
Table 248 | :Egypt Antacid Revenue (2020-2031) & (US$ Million) |
Table 249 | :Key Raw Materials |
Table 250 | :Raw Materials Key Suppliers |
Table 251 | :Antacid Distributors List |
Table 252 | :Antacid Customers List |
Table 253 | :Research Programs/Design for This Report |
Table 254 | :Authors List of This Report |
Table 255 | :Secondary Sources |
Table 256 | :Primary Sources |
List of Figures
Figure 1 | :Antacid Image |
Figure 2 | :Global Antacid Market Size Growth Rate by Type (US$ Million), 2020 VS 2024 VS 2031 |
Figure 3 | :Global Antacid Market Size Share 2020 VS 2024 VS 2031 |
Figure 4 | :Proton Pump Inhibitor Image |
Figure 5 | :H2 Antagonist Image |
Figure 6 | :Acid Neutralizers Image |
Figure 7 | :Global Antacid Market Size Growth Rate by Application (US$ Million), 2020 VS 2024 VS 2031 |
Figure 8 | :Global Antacid Market Size Share 2020 VS 2024 VS 2031 |
Figure 9 | :OTC Drug Image |
Figure 10 | :Rx Drug Image |
Figure 11 | :Global Antacid Revenue (US$ Million), 2020 VS 2024 VS 2031 |
Figure 12 | :Global Antacid Revenue (2020-2031) & (US$ Million) |
Figure 13 | :Global Antacid Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million) |
Figure 14 | :Global Antacid Revenue Market Share by Region: 2024 Versus 2031 |
Figure 15 | :Global Antacid Revenue Market Share by Region (2020-2031) |
Figure 16 | :Global Antacid Sales (2020-2031) & (M Units) |
Figure 17 | :Global Antacid Sales by Region: 2020 VS 2024 VS 2031 (M Units) |
Figure 18 | :Global Antacid Sales Market Share by Region (2020-2031) |
Figure 19 | :US & Canada & Mexico Antacid Sales YoY (2020-2031) & (M Units) |
Figure 20 | :Europe Antacid Sales YoY (2020-2031) & (M Units) |
Figure 21 | :China Antacid Sales YoY (2020-2031) & (M Units) |
Figure 22 | :Asia (Excluding China) Antacid Sales YoY (2020-2031) & (M Units) |
Figure 23 | :South America, Middle East and Africa Antacid Sales YoY (2020-2031) & (M Units) |
Figure 24 | :Global Antacid Manufacturers Revenue Share Top 10 and Top 5 in 2024 |
Figure 25 | :Global Antacid Manufacturers Sales Share Top 10 and Top 5 in 2024 |
Figure 26 | :Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024 |
Figure 27 | :Global Antacid Revenue by Type (2020 VS 2024 VS 2031) & (US$ Million) |
Figure 28 | :Global Antacid Revenue Market Share by Type 2020 VS 2024 VS 2031 |
Figure 29 | :Global Antacid Revenue Market Share by Type (2020-2031) |
Figure 30 | :Global Antacid Sales by Type (2020 VS 2024 VS 2031) & (M Units) |
Figure 31 | :Global Antacid Sales Market Share by Type 2020 VS 2024 VS 2031 |
Figure 32 | :Global Antacid Sales Market Share by Type (2020-2031) |
Figure 33 | :Global Antacid Revenue by Application (2020 VS 2024 VS 2031) & (US$ Million) |
Figure 34 | :Global Antacid Revenue Market Share by Application 2020 VS 2024 VS 2031 |
Figure 35 | :Global Antacid Revenue Market Share by Application (2020-2031) |
Figure 36 | :Global Antacid Sales by Application (2020 VS 2024 VS 2031) & (M Units) |
Figure 37 | :Global Antacid Sales Market Share by Application 2020 VS 2024 VS 2031 |
Figure 38 | :Global Antacid Sales Market Share by Application (2020-2031) |
Figure 39 | :North America Antacid Revenue Share by Type (2020-2031) |
Figure 40 | :North America Antacid Sales Share by Type (2020-2031) |
Figure 41 | :North America Antacid Revenue Share by Application (2020-2031) |
Figure 42 | :North America Antacid Sales Share by Application (2020-2031) |
Figure 43 | :North America Antacid Revenue Share by Country (2020-2031) |
Figure 44 | :North America Antacid Sales Share by Country (2020-2031) |
Figure 45 | :Europe Antacid Revenue Share by Type (2020-2031) |
Figure 46 | :Europe Antacid Sales Share by Type (2020-2031) |
Figure 47 | :Europe Antacid Revenue Share by Application (2020-2031) |
Figure 48 | :Europe Antacid Sales Share by Application (2020-2031) |
Figure 49 | :Europe Antacid Revenue Share by Country (2020-2031) |
Figure 50 | :Europe Antacid Sales Share by Country (2020-2031) |
Figure 51 | :China Antacid Revenue Share by Type (2020-2031) |
Figure 52 | :China Antacid Sales Share by Type (2020-2031) |
Figure 53 | :China Antacid Revenue Share by Application (2020-2031) |
Figure 54 | :China Antacid Sales Share by Application (2020-2031) |
Figure 55 | :Asia Antacid Revenue Share by Type (2020-2031) |
Figure 56 | :Asia Antacid Sales Share by Type (2020-2031) |
Figure 57 | :Asia Antacid Revenue Share by Application (2020-2031) |
Figure 58 | :Asia Antacid Sales Share by Application (2020-2031) |
Figure 59 | :Asia Antacid Revenue Share by Country (2020-2031) |
Figure 60 | :Asia Antacid Sales Share by Country (2020-2031) |
Figure 61 | :SAMEA Antacid Revenue Share by Type (2020-2031) |
Figure 62 | :SAMEA Antacid Sales Share by Type (2020-2031) |
Figure 63 | :SAMEA Antacid Revenue Share by Application (2020-2031) |
Figure 64 | :SAMEA Antacid Sales Share by Application (2020-2031) |
Figure 65 | :SAMEA Antacid Revenue Share by Country (2020-2031) |
Figure 66 | :SAMEA Antacid Sales Share by Country (2020-2031) |
Figure 67 | :Antacid Value Chain |
Figure 68 | :Manufacturing Cost Structure |
Figure 69 | :Antacid Production Mode & Process |
Figure 70 | :Direct Comparison with Distribution Share |
Figure 71 | :Distributors Profiles |
Figure 72 | :Years Considered |
Figure 73 | :Research Process |
Figure 74 | :Key Executives Interviewed |
Request a Sample
Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Pharma & Healthcare
Global Antacid Market Analysis and Forecast 2025-2031
Pages: 195
Complete Your Request
Customer reviews
- 0 out of 5
- 0 Reviews
5
4
3
2
1
No Rating Review Exist.
Write Review
Suggested Report
View MoreNo data found.